Clinical Trial Results
Showing:
All studies
[change]
Condition: COVID-19
Location: Lexington, Massachusetts
18 trials found
New Search
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RECRUITING
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RECRUITING
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
RECRUITING
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RECRUITING
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RECRUITING
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RECRUITING
Defibrotide for the Treatment of Severe COVID-19
RECRUITING
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
RECRUITING
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
Sauna for Long Covid
RECRUITING
COVID-19 Transmission and Morbidity in Malawi
RECRUITING
Mind Body Intervention for Long COVID-19
RECRUITING
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
RECRUITING
Testimonials and Navigation in Rheumatology
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RECRUITING
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RECRUITING
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RECRUITING